8-K ·Filed May 8, 2026
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight ▲ Bullish
The $2M settlement boosts cash but is non-recurring. Monitor ImmuCell's next earnings call for any impact on working capital or reinvestment plans.
Final — all horizons settled through T+60d
ICCC ▲ +27.22% at T+60d
LONG call ✓ call won +27.22% · α vs SPY +22.83% · entry $8.45 → $10.75
T+1d
-0.83%
call -0.83% · α -0.69%
$8.38
settled 6mo ago
T+5d
+17.28%
call +17.28% · α +17.36%
$9.91
settled 6mo ago
T+20d
+15.62%
call +15.62% · α +15.93%
$9.77
settled 5mo ago
T+60d
+27.22%
call +27.22% · α +22.83%
$10.75
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
ImmuCell and Norbrook signed a Settlement Deed resolving claims from a 2019 agreement; Norbrook pays ImmuCell $2M. The settlement provides a cash inflow but is a one-time event with no admission of liability.
Key Financial Metrics
Deal Value
$2.0M
Key Facts
- Settlement Deed with Norbrook Laboratories Limited executed May 8, 2026
- Norbrook to pay ImmuCell $2,000,000
- Resolves all claims under 2019 Development Services and Commercial Supply Agreement that expired March 31, 2026
- No admission of liability by either party
Financial Impact
$2,000,000 cash payment to ImmuCell, representing ~2.6% of market cap
cash
Risk Factors
- Settlement is a one-time event with no ongoing revenue benefit
- No additional business relationship with Norbrook implied
Market Snapshot
Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
86% bullish (7 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-015945 |
| Document: 0001437749-26-015945-index-headers.html | 0001437749-26-015945 |
| Document: 0001437749-26-015945-index.html | 0001437749-26-015945 |
| Document: 0001437749-26-015945.txt | 0001437749-26-015945 |
6 reports for ICCC
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 8-K | $10.79 $10.45 | ▼ −3.15% | ▼ −2.00% | $10.25 (−5.00%) |
May 8, 2026 24w ago | 8-K | $8.45 $9.91 | ▲ +17.28% | ▲ +17.36% | $10.25 (+21.30%) |
Apr 8, 2026 28w ago | 8-K | $7.19 $7.54 | ▲ +4.87% | ▲ +1.68% | $10.25 (+42.56%) |
Apr 8, 2026 28w ago | Press Release | $7.19 $7.54 | ▲ +4.87% | ▲ +1.68% | $10.25 (+42.56%) |
Mar 4, 2026 33w ago | 8-K | $6.35 $6.63 | ▲ +4.41% | ▲ +6.65% | $10.25 (+61.42%) |
Mar 4, 2026 33w ago | Press Release | $6.35 $6.63 | ▲ +4.41% | ▲ +6.65% | $10.25 (+61.42%) |
Showing 6 of 6
US Market Status
Market Closed — Opens Wed (12h 44m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers